Staar Surgical scrapped its outlook for fiscal-year 2025, citing global economic uncertainty and evolving tariff policies that have made forecasting future quarters too challenging.

Medical lens company STAAR Surgical (NASDAQ:STAA) reported Q1 CY2025 results exceeding the market’s revenue expectations, but ...